ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
85 Ergebnisse für "mater" unter ETH Entrepreneurship
[ACS Appl. Mater. Interfaces] Low Temperature Wet Confocal Nickel S...
... [ACS Appl. Mater. Interfaces] Low Temperature Wet Confocal Nickel Silicide Deposition on Silicon ... [ACS Appl. Mater. Interfaces] Low Temperature Wet Confocal Nickel Silicide Deposition on Silicon ... https://shihlab.ethz.ch/lise-news/lab-news/2017/03/acs-appl- mater-interfaces-low-temperature-wet ... [ACS Appl. Mater. Interfaces] Low Temperature Wet Confocal Nickel Silicide Deposition on Silicon ...
[J. Mater. Chem. C] Layer-Controlled Two-Dimensional Perovskites: S...
... [J. Mater. Chem. C] Layer-Controlled Two-Dimensional Perovskites: Synthesis and Optoelectronics ... [J. Mater. Chem. C] Layer-Controlled Two-Dimensional Perovskites: Synthesis and Optoelectronics ... https://shihlab.ethz.ch/lise-news/lab-news/2017/05/j- mater-chem-c-layer-controlled-two-dimensional ... [J. Mater. Chem. C] Layer-Controlled Two-Dimensional Perovskites: Synthesis and Optoelectronics ...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
290 Ergebnisse für "mater" unter Somagenetix
Multi-perspective application selection: a method to identify susta...
... mater ... mater ...
Infection burden and immunological responses are equivalent for pol...
... properties. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res B Part B, 2018. Abstract The development of an ... Periodicals, Inc. J Biomed Mater Res B Part B, 2018. ... mater ... Periodicals, Inc. J Biomed Mater Res B Part B, 2018. Abstract The development of an infection is a major ... mater ...
Kuros Biosciences AG
8952 Schlieren, Wagistrasse 25
+41 (0)44 733 4747
Our focus is on revolutionizing the field of orthobiologics by developing bone grafts that deliver both targeted and controlled bone healing.
Kuros Biosciences AG
Wagistrasse 25
8952 Schlieren
32 Ergebnisse für "mater" unter Kuros Biosciences AG
Kuros BioSciences - A novel, tissue occlusive poly(ethylene glycol)...
... Wechsler S, Fehr D, Molenberg A, Raeber G, Schense JC, Weber FE. J Biomed Mater Res A. 2008 May;85 ... , Fehr D, Molenberg A, Raeber G, Schense JC, Weber FE. J Biomed Mater Res A. 2008 May;85(2):285-92. ...
Kuros BioSciences - Surgical Sealants
... gastrointestinal tract, lobes of the lung or of the dura mater surrounding the brain and spinal cord. Kuros ... gastrointestinal tract, lobes of the lung or of the dura mater surrounding the brain and spinal cord. Kuros ... lung or of the dura mater surrounding the brain and spinal cord. Kuros’ technology can be tailored to ... gastrointestinal tract, lobes of the lung or of the dura mater surrounding the brain and spinal cord. Kuros ...
University Hospital Zurich, Research and Education Office
https://www.usz.ch/forschung/Seiten/default.aspx
8091 Zürich, Rämistrasse 100
The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.
University Hospital Zurich, Research and Education Office
Rämistrasse 100
8091 Zürich
10 Ergebnisse für "mater" unter University Hospital Zurich, Research and Education Office
Slide S VII 21
... , 1.5 cm dickes Meningeom der Dura mater an der Falx (Falxmeningeom). - Die Tumorzellen bilden ein ... -old male. Incidental postmortem finding. The meningioma of the falx of the dura mater (falx ... cm langes, 1.5 cm dickes Meningeom der Dura mater an der Falx (Falxmeningeom). - Die Tumorzellen ... . Incidental postmortem finding. The meningioma of the falx of the dura mater (falx meningioma) is ...
Slide A IV 8
... bacterial meningitis ICD-10: G00 - Pia mater von der Hirnoberfläche teilweise ... Lichteinfall, hohes Fieber, Verwirrtheit. Autopsiepräparat - Kleinhirn - Pia mater von der Hirnoberfläche ... teilweise abgehoben - In der Pia mater herdförmig dichte Infiltrate neutrophiler Granulozyten , die sich ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
82 Ergebnisse für "mater" unter University of Zurich
UZH - Institute of Anatomy - Research
... studies are: The architecture of the quadriceps tendon The venous system of the Dura Mater The femoral ... The venous system of the Dura Mater The femoral entry point in MPFL reconstruction, The accuracy of ...
UZH - Science Alumni UZH - Science Alumni UZH
... mater. We love to organize public lectures and discussion events, offer an exclusive look behind the ... students and employees of the faculty and their alma mater. We love to organize public lectures and ...
CUTISS AG
8952 Schlieren, Grabenstrasse 11
+41 44 244 36 60
info@cutiss.swiss
After more than 15 years of research (Tissue Biology Research Unit, University Children’s Hospital Zurich), CUTISS AG can now bio-engineer large quantities of individually customized human skin grafts, denovoSkin™, starting off from a very small piece of healthy patient’s skin. Because of its intrinsic characteristics, denovoSkin™ is expected to result in a minimally scarring outcome after transplantation. denovoSkin™ received a Swissmedic, EMA and FDA Orphan drug designation for the treatment of burns.
CUTISS AG
Grabenstrasse 11
8952 Schlieren
3 Ergebnisse für "mater" unter CUTISS AG
Clinical Development – CUTISS
... , Mazza E. J Mech Behav Biomed Mater. 2017 May;69:85-97 Bioengineering dermo-epidermal skin grafts with ... Pensalfini M, Ehret A, Stüdeli S, Marino D, Kaech A, Reichmann E, Mazza E. J Mech Behav Biomed Mater. 2017 ...
Clinical Development – CUTISS
... , Mazza E. J Mech Behav Biomed Mater. 2017 May;69:85-97 Bioengineering dermo-epidermal skin grafts with ... Pensalfini M, Ehret A, Stüdeli S, Marino D, Kaech A, Reichmann E, Mazza E. J Mech Behav Biomed Mater. 2017 ...
InSphero AG
8952 Schlieren, Wagistrasse 27
+41 44 515049-0
info@insphero.com
InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company currently counts all of the top ten global pharmaceutical and cosmetics companies as customers and is helping them to implement its patented microtissue technology in their development work-flow.
InSphero AG
Wagistrasse 27
8952 Schlieren
4 Ergebnisse für "mater" unter InSphero AG
Insphero
... engineering Walser R, Metzger W, Görg A, Pohlemann T, Menger MD, Laschke MW. Eur Cell Mater. 2013; 26:222-33 ... . Eur Cell Mater. 2013; 26:222-33. This publication highlights the use spheroids as building units for ...
Insphero
... engineering Walser R, Metzger W, Görg A, Pohlemann T, Menger MD, Laschke MW. Eur Cell Mater. 2013; 26:222-33 ... . Eur Cell Mater. 2013; 26:222-33. This publication highlights the use spheroids as building units for ...
Vivtex
8952 Schlieren, Wagistrasse 13
Vivtex’s proprietary platform enables for the first time the use of intact gastrointestinal tract tissue for fully automated robotic testing. We use this technology to enable the development of new drugs that can be given orally instead of painful and inconvenient needle injections.
Vivtex
Wagistrasse 13
8952 Schlieren
1 Ergebnisse für "mater" unter Vivtex
Screening oral drugs for their interactions with the intestinal tra...
Screening oral drugs for their interactions with the intestinal transportome via porcine tissue expl, https://vivtex.com/wp-content/uploads/2024/05/Screening-oral-drugs-for-their-interactions.pdf,...
Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
2 Ergebnisse für "mater" unter Roche Glycart AG
untitled
untitled, https://diagnostics.roche.com/content/dam/diagnostics/Blueprint/en/pdf/rmd/2014-ESC-Guidelines-on-the-diagnosis-and-management-of-acute-pulmonary-embolism.pdf, untitled ESC GUIDELINES 20...
OP-EHEA190412 1..61
OP-EHEA190412 1..61, https://diagnostics.roche.com/content/dam/diagnostics/Blueprint/en/pdf/rmd/2019-ESC-Guidelines-on-the-diagnosis-and-management-of-acute-pulmonary-embolism.pdf, OP-EHEA190412 1...